New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 9, 2012
05:58 EDTCPIXCumberland downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded Cumberland Pharmaceuticals citing risk to the Acetadote franchise after the FDA approved Innopharma's potential generic. The firm lowered its price target range for shares to $6-$7 from $8-$9.
News For CPIX From The Last 14 Days
Check below for free stories on CPIX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CPIX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use